Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Reliability of acute illness dihydrorhodamine-123 testing for chronic granulomatous disease.

Ang EY, Soh JY, Liew WK, Chan KW, Thoon KC, Chong CY, Lau YL, Lee BW.

Clin Lab. 2013;59(1-2):203-6. Erratum in: Clin Lab. 2013;59(3-4):449. Ang, Y N [corrected to Ang, E Y]; Chan, K W [added]; Thoon, K C [added]; Chong, C Y [added]; Lau, Y L [added].

PMID:
23505928
2.

Diagnostic paradigm for evaluation of male patients with chronic granulomatous disease, based on the dihydrorhodamine 123 assay.

Jirapongsananuruk O, Malech HL, Kuhns DB, Niemela JE, Brown MR, Anderson-Cohen M, Fleisher TA.

J Allergy Clin Immunol. 2003 Feb;111(2):374-9.

PMID:
12589359
3.

Chronic granulomatous disease (CGD) and complete myeloperoxidase deficiency both yield strongly reduced dihydrorhodamine 123 test signals but can be easily discerned in routine testing for CGD.

Mauch L, Lun A, O'Gorman MR, Harris JS, Schulze I, Zychlinsky A, Fuchs T, Oelschlägel U, Brenner S, Kutter D, Rösen-Wolff A, Roesler J.

Clin Chem. 2007 May;53(5):890-6. Epub 2007 Mar 23.

4.

Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes.

Vowells SJ, Sekhsaria S, Malech HL, Shalit M, Fleisher TA.

J Immunol Methods. 1995 Jan 13;178(1):89-97.

PMID:
7829869
5.

Diagnosis and carrier detection of chronic granulomatous disease in five families by flow cytometry.

Crockard AD, Thompson JM, Boyd NA, Haughton DJ, McCluskey DR, Turner CP.

Int Arch Allergy Immunol. 1997 Oct;114(2):144-52.

PMID:
9338608
6.

Detection of inheritance pattern in thirty-three Mexican males with chronic granulomatous disease through 123 dihydrorhodamine assay.

Berrón-Ruiz L, Morín-Contreras A, Cano-García V, Yamazaki-Nakashimada MA, Gómez-Tello H, Vargas-Camaño ME, Canseco-Raymundo R, Saracho-Weber F, Pietropaolo-Cienfuegos D, Del Río-Navarro B, Staines-Boone T, Espinosa-Rosales F, González-Del Ángel A, Saenz-de-Ocaris MM, Pacheco-Rosas D, Espinosa-Padilla S, Santos-Argumedo L, Blancas-Galicia L.

Allergol Immunopathol (Madr). 2014 Nov-Dec;42(6):580-5. doi: 10.1016/j.aller.2013.07.014. Epub 2014 Jun 2.

PMID:
24890515
7.
8.

Evaluation of flow cytometric methods for diagnosis of chronic granulomatous disease variants under routine laboratory conditions.

Emmendörffer A, Nakamura M, Rothe G, Spiekermann K, Lohmann-Matthes ML, Roesler J.

Cytometry. 1994 Sep 15;18(3):147-55.

9.

Diagnosis of chronic granulomatous disease and of its mode of inheritance by dihydrorhodamine 123 and flow microcytofluorometry.

Roesler J, Hecht M, Freihorst J, Lohmann-Matthes ML, Emmendörffer A.

Eur J Pediatr. 1991 Jan;150(3):161-5.

PMID:
2044584
10.

The relationship between alloimmunization and posttransfusion granulocyte survival: experience in a chronic granulomatous disease cohort.

Heim KF, Fleisher TA, Stroncek DF, Holland SM, Gallin JI, Malech HL, Leitman SF.

Transfusion. 2011 Jun;51(6):1154-62. doi: 10.1111/j.1537-2995.2010.02993.x. Epub 2010 Dec 22.

11.

Focus on FOCIS: the continuing diagnostic challenge of autosomal recessive chronic granulomatous disease.

Yu G, Hong DK, Dionis KY, Rae J, Heyworth PG, Curnutte JT, Lewis DB.

Clin Immunol. 2008 Aug;128(2):117-26. doi: 10.1016/j.clim.2008.05.008.

PMID:
18625437
13.

Skewing of X-chromosome inactivation in three generations of carriers with X-linked chronic granulomatous disease within one family.

Köker MY, Sanal O, de Boer M, Tezcan I, Metin A, Tan C, Ersoy F, Roos D.

Eur J Clin Invest. 2006 Apr;36(4):257-64.

PMID:
16620288
14.

Neutrophil function screening in patients with chronic granulomatous disease by a flow cytometric method.

Epling CL, Stites DP, McHugh TM, Chong HO, Blackwood LL, Wara DW.

Cytometry. 1992;13(6):615-20.

15.

Chronic granulomatous disease assessed by single-cell granulocyte oxidative burst activity.

Wolf H, Frühwirth M, Ruedl C, Oswald HP, Fischer H, Böck G, Wick G.

Int Arch Allergy Immunol. 1995 Apr;106(4):425-7.

PMID:
7719159
16.

X-linked carriers of chronic granulomatous disease: Illness, lyonization, and stability.

Marciano BE, Zerbe CS, Falcone EL, Ding L, DeRavin SS, Daub J, Kreuzburg S, Yockey L, Hunsberger S, Foruraghi L, Barnhart LA, Matharu K, Anderson V, Darnell DN, Frein C, Fink DL, Lau KP, Long Priel DA, Gallin JI, Malech HL, Uzel G, Freeman AF, Kuhns DB, Rosenzweig SD, Holland SM.

J Allergy Clin Immunol. 2017 May 18. pii: S0091-6749(17)30763-7. doi: 10.1016/j.jaci.2017.04.035. [Epub ahead of print]

PMID:
28528201
17.

Chronic granulomatous disease in pediatric patients: 25 years of experience.

Soler-Palacín P, Margareto C, Llobet P, Asensio O, Hernández M, Caragol I, Español T.

Allergol Immunopathol (Madr). 2007 May-Jun;35(3):83-9.

PMID:
17594870
18.

Further characterization of the neutrophil oxidative burst by flow cytometry.

Smith JA, Weidemann MJ.

J Immunol Methods. 1993 Jun 18;162(2):261-8.

PMID:
8315293
19.

A radiometric whole blood test for chronic granulomatous disease.

Strate M, Elkjaer D, Wang P.

Scand J Clin Lab Invest. 1984 Sep;44(5):417-21.

PMID:
6435234
20.

Supplemental Content

Support Center